Heptromic. Genomic predictors and oncogenic drivers in hepatocellurlar carcinoma

  • Heptromic Genomic predictors and oncogenic drivers in hepatocellular carcinoma. Watch the video
  • Heptromic will optimise decision-making for liver cancer patients by identifying genomic prognostic determinants and oncogenic drivers.
  • Heptromic’s core team comprises leading European researchers in the basic, translational and clinical fields of liver cancer.
  • Heptromic is a 3-year translational research project which aims to solve core problems in the management of hepatocellular carcinoma (HCC), the third most common cause of cancer-related death worldwide.

Events

potentiometric

RSS

Scientific Publications

(361) 937-6077

Heptromic Partners

631-705-5540

Prof. Jessica Zucman-Rossi

Institut National de la Santé et de la Recherche Médicale

Prof. Jessica Zucman-Rossi

Next generation sequencing

Project led by: 7783714934

Copyright © 2010 - 2019 HEPTROMIC

HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.